RESUMEN
Secondary aortoesophageal fistula (AEF) is a rare but catastrophic complication that occurs after thoracic aortic reconstruction. Recently endoluminal stent grafts have been used in selected patients with a thoracic aortic aneurysm, dissection, or traumatic aortic transection. A 24-year-old woman had massive upper gastrointestinal tract bleeding 15 months after endoluminal stent graft placement because of traumatic descending thoracic aortic transection. Evaluation demonstrated an AEF from the mid-esophagus to the endoluminal stent graft. The endoluminal graft was explanted, with primary repair of the thoracic aortic defect and simultaneous primary repair of the esophageal injury. The patient is well 15 months after open repair of the AEF.
Asunto(s)
Aorta Torácica/lesiones , Enfermedades de la Aorta/cirugía , Implantación de Prótesis Vascular/efectos adversos , Fístula Esofágica/cirugía , Stents/efectos adversos , Heridas no Penetrantes/complicaciones , Accidentes de Tránsito , Adulto , Aneurisma Falso/etiología , Aneurisma Falso/cirugía , Angioplastia/efectos adversos , Enfermedades de la Aorta/etiología , Procedimientos Quirúrgicos del Sistema Digestivo , Fístula Esofágica/etiología , Femenino , Hematemesis/etiología , Hematemesis/cirugía , Humanos , Procedimientos Quirúrgicos Vasculares , Heridas no Penetrantes/cirugíaRESUMEN
We report a unusual case of an inflammatory myofibroblastic tumor arising at the gastroesophageal junction in a 14-year-old girl. The bland histologic appearance with concurrent infiltration into adjacent structures made diagnostic interpretation difficult, but suggested a neoplastic process. A literature review was undertaken to address diagnostic and management issues raised in this case. Although the anatomic location was unusual, clinical, grass, histopathologic, and immunohistochemical data substantiated the diagnosis of inflammatory myofibroblastic tumor. The bland histologic appearance was consistent with the most widely accepted view of inflammatory myofibroblastic tumor as a low-grade neoplasm. Wide surgical excision was performed. This is considered the preferred treatment given the potential risk of recurrence and aggressive behavior, most frequently noted with extrapulmonary disease. Although inflammatory myofibroblastic tumor represents an heterologous spectrum of benign to malignant neoplastic proliferations, the prognosis is good in casts with benign histologic features.